Cargando…
Is a third SARS‐CoV‐2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?
When and how often should allogeneic haematopoietic cell transplantation recipients be vaccinated against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is unclear. The report by Bankova et al. suggests that a third SARS‐CoV‐2 vaccine dose is important but still insufficient in some pa...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878174/ https://www.ncbi.nlm.nih.gov/pubmed/36477621 http://dx.doi.org/10.1111/bjh.18591 |